Ascentage Pharma Group International American Depository Shares (AAPG)
AAPG trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC 20-F (ifrs-full:Revenue), period ending 2024-12-31, https://www.sec.gov/Archives/edgar/data/2023311/000121390025032599/0001213900-25-032599-index.htm. Net income: SEC 20-F (ifrs-full:ProfitLossAttributableToOwnersOfParent), period ending 2024-12-31. Converted from CNY at 6.6927 per USD (ECB reference rate).
Profile
| Field | Value |
|---|---|
| Ticker | AAPG on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | China |
| IPO year | 2025 |
| SEC CIK | 0002023311 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | E9 |
Financials · 2024
| Line | Value |
|---|---|
| Revenue | $146.5M |
| Net income | -$60.6M |
| Operating income | Not in SEC XBRL data |
| Net margin | -41.3% |
| Operating margin | Operating income not reported |
| Revenue growth | No prior-year revenue to compare |
| Cash | Not in SEC XBRL data |
| Total assets | Not in SEC XBRL data |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 9.6× |
Reported in CNY; shown in US dollars.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B4 | 2025-01-24 |
| Latest annual report ANNUAL REPORT | 20-F | 2026-04-29 |
| Latest quarterly / interim REPORT OF FOREIGN PRIVATE ISSUER | 6-K | 2026-09-29 |
Source: SEC EDGAR submissions feed, 128 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -6.4% |
| 1 month | -8.2% |
| 3 months | -25.4% |
| Year to date | -42.6% |
| 1 year | -56.9% |
| From 52-week high | -59.2% |
Source: Yahoo Finance daily closes, last bar 2026-10-13. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| KLRA | Kailera Therapeutics Inc. | $10.77 | -4.94% | $1.4B |
| RAPP | Rapport Therapeutics Inc. | $28.99 | -3.85% | $1.4B |
| KRSA | Korsana Biosciences Inc. | $31.66 | -6.99% | $1.4B |
| OMER | Omeros Corporation | $18.88 | -3.82% | $1.4B |
| PCRX | Pacira BioSciences Inc. | $36.31 | -0.11% | $1.4B |
| STOK | Stoke Therapeutics Inc. | $22.50 | -6.83% | $1.5B |
| ANAB | AnaptysBio Inc. | $45.59 | -0.98% | $1.3B |
| RARE | Ultragenyx Pharmaceutical Inc. | $14.92 | -2.48% | $1.5B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier